The Harvard Stem Cell Institute (HSCI) Kidney Program invites applications for up to two Program Grant and up to two Pilot Grants for 2012. The purpose of this funding program is to provide resources for research in adult kidney disease with the goal of developing new therapeutic strategies. As such, a critical component is the translatability of the research project. This may take many forms, and does not require human subjects research, however thought should be given as to how funds will be best used to ultimately bring new therapies to the clinic. Preference will be given to projects focused on the adult kidney, for which current funding sources are not available and where clinical potential is high. Read more about 2012 HSCI call for proposals – Kidney Program pilot grants
The Harvard Stem Cell Institute (HSCI) invites applications for seed grants funding. The purpose of this program is to provide early funding for innovative projects in the field of stem cell research including basic, translational and clinical research.
If you are considering giving a gift to HSCI in tax year 2011, there are a few factors to keep in mind to make sure that Harvard is able to give you a tax receipt for calendar year 2011 instead of 2012. Mutual funds must be received in Harvard’s account no later than 12/12/2011. If you are sending a check, please make sure that the envelope is postmarked no later than 12/31/2011, or, if you are using a service other than US Mail, that the package arrives at Harvard no later than 12/31/2011. Credit card donations must be charged to your account no later than 12/31/2011. … Read more about 2011 end of year giving
Doug Melton, co-founding director of the Harvard Stem Cell Institute (HSCI), a leading stem cell and regenerative biologist, and one of the driving forces behind Harvard's ascendency to world leadership in the field, has been named a University Professor, Harvard's highest professorial distinction.
Program Overview: The Harvard Stem Cell Institute (HSCI) Cancer Program invites applications for pilot grants funding for 2011. The purpose of this funding program is to provide resources for innovative projects by investigators in the field of cancer stem cell biology, including basic, translational or clinical research. This funding is for groundbreaking, innovative, high- impact research projects that could fundamentally enhance biomedical research. Particularly welcomed are applications that promote the Program mission: to identify critical genes and pathways that sufficiently distinguish cancer from normal stem cells and hence serve as candidate targets for therapy.